IMPORTANCE: Prion diseases represent the archetype of brain diseases caused by protein misfolding, with the most common subtype being sporadic Creutzfeldt-Jakob disease (sCJD), a rapidly progressive dementia. Diffusion-weighted imaging (DWI) has emerged as the most sensitive magnetic resonance imaging (MRI) sequence for the diagnosis of sCJD, but few studies have assessed the evolution of MRI signal as the disease progresses. OBJECTIVES: To assess the natural history of the MRI signal abnormalities on DWI in sCJD to improve our understanding of the pathogenesis and to investigate the potential of DWI as a biomarker of disease progression, with histopathological correlation. DESIGN, SETTING, AND PARTICIPANTS: Gray matter involvement on DWI was assessed among 37 patients with sCJD in 26 cortical and 5 subcortical subdivisions per hemisphere using a semiquantitative scoring system of 0 to 2 at baseline and follow-up. A total brain score was calculated as the summed scores in the individual regions. In 7 patients, serial mean diffusivity measurements were obtained. Age at baseline MRI, disease duration, atrophy, codon 129 methionine valine polymorphism, Medical Research Council Rating Scale score, and histopathological findings were documented. The study setting was the National Prion Clinic, London, England. All participants had a probable or definite diagnosis of sCJD and had at least 2 MRI studies performed during the course of their illness. The study dates were October 1, 2008 to April 1, 2012. The dates of our analysis were January 19 to April 20, 2012. MAIN OUTCOMES AND MEASURES: Correlation of regional and total brain scores with disease duration. RESULTS: Among the 37 patients with sCJD in this study there was a significant increase in the number of regions demonstrating signal abnormality during the study period, with 59 of 62 regions showing increased signal intensity (SI) at follow-up, most substantially in the caudate and putamen (P < .001 for both). The increase in the mean (SD) total brain score from 30.2 (17.3) at baseline to 40.5 (20.6) at follow-up (P = .001) correlated with disease duration (r = 0.47, P = .003 at baseline and r = 0.35, P = .03 at follow-up), and the left frontal SI correlated with the degree of spongiosis (r = 0.64, P = .047). Decreased mean diffusivity in the left caudate at follow-up was seen (P < .001). Eight patients demonstrated decreased SI in cortical regions, including the left inferior temporal gyrus and the right lingual gyrus. CONCLUSIONS AND RELEVANCE: Magnetic resonance images in sCJD show increased extent and degree of SI on DWI that correlates with disease duration and the degree of spongiosis. Although cortical SI may fluctuate, increased basal ganglia SI is a consistent finding and is due to restricted diffusion. Diffusion-weighted imaging in the basal ganglia may provide a noninvasive biomarker in future therapeutic trials.
IMPORTANCE: Prion diseases represent the archetype of brain diseases caused by protein misfolding, with the most common subtype being sporadic Creutzfeldt-Jakob disease (sCJD), a rapidly progressive dementia. Diffusion-weighted imaging (DWI) has emerged as the most sensitive magnetic resonance imaging (MRI) sequence for the diagnosis of sCJD, but few studies have assessed the evolution of MRI signal as the disease progresses. OBJECTIVES: To assess the natural history of the MRI signal abnormalities on DWI in sCJD to improve our understanding of the pathogenesis and to investigate the potential of DWI as a biomarker of disease progression, with histopathological correlation. DESIGN, SETTING, AND PARTICIPANTS: Gray matter involvement on DWI was assessed among 37 patients with sCJD in 26 cortical and 5 subcortical subdivisions per hemisphere using a semiquantitative scoring system of 0 to 2 at baseline and follow-up. A total brain score was calculated as the summed scores in the individual regions. In 7 patients, serial mean diffusivity measurements were obtained. Age at baseline MRI, disease duration, atrophy, codon 129 methionine valine polymorphism, Medical Research Council Rating Scale score, and histopathological findings were documented. The study setting was the National Prion Clinic, London, England. All participants had a probable or definite diagnosis of sCJD and had at least 2 MRI studies performed during the course of their illness. The study dates were October 1, 2008 to April 1, 2012. The dates of our analysis were January 19 to April 20, 2012. MAIN OUTCOMES AND MEASURES: Correlation of regional and total brain scores with disease duration. RESULTS: Among the 37 patients with sCJD in this study there was a significant increase in the number of regions demonstrating signal abnormality during the study period, with 59 of 62 regions showing increased signal intensity (SI) at follow-up, most substantially in the caudate and putamen (P < .001 for both). The increase in the mean (SD) total brain score from 30.2 (17.3) at baseline to 40.5 (20.6) at follow-up (P = .001) correlated with disease duration (r = 0.47, P = .003 at baseline and r = 0.35, P = .03 at follow-up), and the left frontal SI correlated with the degree of spongiosis (r = 0.64, P = .047). Decreased mean diffusivity in the left caudate at follow-up was seen (P < .001). Eight patients demonstrated decreased SI in cortical regions, including the left inferior temporal gyrus and the right lingual gyrus. CONCLUSIONS AND RELEVANCE: Magnetic resonance images in sCJD show increased extent and degree of SI on DWI that correlates with disease duration and the degree of spongiosis. Although cortical SI may fluctuate, increased basal ganglia SI is a consistent finding and is due to restricted diffusion. Diffusion-weighted imaging in the basal ganglia may provide a noninvasive biomarker in future therapeutic trials.
Authors: R Fukushima; Y Shiga; M Nakamura; J Fujimori; T Kitamoto; Y Yoshida Journal: J Neurol Neurosurg Psychiatry Date: 2004-03 Impact factor: 10.154
Authors: Henriette J Tschampa; Petra Mürtz; Sebastian Flacke; Sebastian Paus; Hans H Schild; Horst Urbach Journal: AJNR Am J Neuroradiol Date: 2003-05 Impact factor: 3.825
Authors: B Meissner; K Kallenberg; P Sanchez-Juan; A Krasnianski; U Heinemann; D Varges; M Knauth; I Zerr Journal: AJNR Am J Neuroradiol Date: 2008-07-03 Impact factor: 3.825
Authors: E Caverzasi; R G Henry; P Vitali; I V Lobach; J Kornak; S Bastianello; S J Dearmond; B L Miller; H J Rosen; M L Mandelli; M D Geschwind Journal: Neuroimage Clin Date: 2014-01-31 Impact factor: 4.881
Authors: Andrew G B Thompson; Jessica Lowe; Zoe Fox; Ana Lukic; Marie-Claire Porter; Liz Ford; Michele Gorham; Gosala S Gopalakrishnan; Peter Rudge; A Sarah Walker; John Collinge; Simon Mead Journal: Brain Date: 2013-04 Impact factor: 13.501
Authors: Jeremy A Elman; Matthew S Panizzon; Donald J Hagler; Christine Fennema-Notestine; Lisa T Eyler; Nathan A Gillespie; Michael C Neale; Michael J Lyons; Carol E Franz; Linda K McEvoy; Anders M Dale; William S Kremen Journal: Neuroimage Date: 2016-11-15 Impact factor: 6.556
Authors: Peter Hermann; Brian Appleby; Jean-Philippe Brandel; Byron Caughey; Steven Collins; Michael D Geschwind; Alison Green; Stephane Haïk; Gabor G Kovacs; Anna Ladogana; Franc Llorens; Simon Mead; Noriyuki Nishida; Suvankar Pal; Piero Parchi; Maurizio Pocchiari; Katsuya Satoh; Gianluigi Zanusso; Inga Zerr Journal: Lancet Neurol Date: 2021-03 Impact factor: 44.182
Authors: Kyan Younes; Julio C Rojas; Amy Wolf; Goh M Sheng-Yang; Matteo Paoletti; Gianina Toller; Eduardo Caverzasi; Maria Luisa Mandelli; Ignacio Illán-Gala; Joel H Kramer; Yann Cobigo; Bruce L Miller; Howard J Rosen; Michael D Geschwind Journal: Ann Clin Transl Neurol Date: 2021-05-05 Impact factor: 4.511
Authors: Neetu Soni; Manish Ora; Girish Bathla; Chandana Nagaraj; Laura L Boles Ponto; Michael M Graham; Jitender Saini; Yusuf Menda Journal: Neuroradiol J Date: 2021-03-05
Authors: Enrico De Vita; Gerard R Ridgway; Mark J White; Marie-Claire Porter; Diana Caine; Peter Rudge; John Collinge; Tarek A Yousry; Hans Rolf Jager; Simon Mead; John S Thornton; Harpreet Hyare Journal: Neuroimage Clin Date: 2016-11-02 Impact factor: 4.881
Authors: Riccardo Pascuzzo; Neil P Oxtoby; Alexandra L Young; Janis Blevins; Gianmarco Castelli; Sara Garbarino; Mark L Cohen; Lawrence B Schonberger; Pierluigi Gambetti; Brian S Appleby; Daniel C Alexander; Alberto Bizzi Journal: Acta Neuropathol Date: 2020-06-13 Impact factor: 17.088
Authors: Harpreet Hyare; Enrico De Vita; Marie-Claire Porter; Ivor Simpson; Gerard Ridgway; Jessica Lowe; Andrew Thompson; Chris Carswell; Sebastien Ourselin; Marc Modat; Liane Dos Santos Canas; Diana Caine; Zoe Fox; Peter Rudge; John Collinge; Simon Mead; John S Thornton Journal: Brain Commun Date: 2020-04-08